Copying and distributing are prohibited without permission of the publisher.

Watermark

Bayer's $14.2bn loan a coup for Mizuho

drugs are bad, mmmk? (right size)
By Michael Turner
18 Jun 2014

Bayer, the German chemicals and pharmaceuticals firm, has signed the $14.2bn acquisition finance facility backing its purchase of Merck & Co's consumer care business.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Michael Turner
18 Jun 2014